23-epi-26-Deoxyactein
CAS No. 264624-38-6
23-epi-26-Deoxyactein ( 27-Deoxyactein )
Catalog No. M24175 CAS No. 264624-38-6
23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 300 | In Stock |
|
10MG | 511 | In Stock |
|
25MG | 807 | In Stock |
|
50MG | 1062 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name23-epi-26-Deoxyactein
-
NoteResearch use only, not for human use.
-
Brief Description23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
-
Description23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
-
Synonyms27-Deoxyactein
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK;NO Synthase;NOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number264624-38-6
-
Formula Weight660.8
-
Molecular FormulaC37H56O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@H](C[C@]1(OC[C@@]2(C)O[C@@H]12)O[C@H]1C2)[C@@H]1[C@@](C)([C@@H](C1)OC(C)=O)[C@]2(C)[C@H](CC2)[C@]1(C1)[C@@]1(CC1)[C@@H]2C(C)(C)[C@H]1O[C@@H]([C@@H]([C@H]1O)O)OC[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells.Breast Cancer Res Treat. 2004 Feb;83(3):221-31.
molnova catalog
related products
-
BML-259
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
-
CCT-251921
A potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively.
-
RO5454291
RO5258638 is a small molecule inhibitor of CDK5-p25 protein-protein interaction with IC50 of 1.39 uM.